Uterine Cancer
Uterine cancer, also known as endometrial cancer, is a type of cancer that affects the lining of the uterus, the endometrium. This type of cancer occurs when abnormal cells grow in the endometrium, forming a tumour. It is the most common gynecologic cancer in women and the fourth most common cancer overall in women in the United States. There are several risk factors for developing uterine cancer. Some of these risk factors include increasing age, obesity, hormonal imbalances, taking certain medications (such as tamoxifen), having a history of breast or ovarian cancer, and having a family history of uterine or colon cancer. The most common symptom of uterine cancer is abnormal vaginal bleeding, particularly after menopause. Uterine cancer is usually diagnosed through a combination of physical exams, imaging tests, and biopsies. Treatment for uterine cancer typically involves a combination of surgery, radiation therapy, and/or chemotherapy. The specific treatment plan will depend on several factors, including the stage of the cancer and the patient's overall health. Research in hematology and oncology is ongoing in the field of uterine cancer. Studies are exploring the effectiveness of new treatments, such as immunotherapy and targeted therapy, as well as the role of genetic testing in identifying high-risk individuals who may benefit from early detection and prevention strategies. It is important for women to be aware of their risk factors and consult with their healthcare provider if they experience any unusual symptoms or concerns.
← Hematology Research and Oncology Research